Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphotoxin-alpha | 9 | 2006 | 44 | 0.790 |
Why?
|
| Transcription Factors | 4 | 2006 | 1665 | 0.350 |
Why?
|
| Thymus Gland | 3 | 2007 | 197 | 0.340 |
Why?
|
| Receptors, Tumor Necrosis Factor | 9 | 2006 | 90 | 0.290 |
Why?
|
| Collagen Type II | 1 | 2006 | 14 | 0.270 |
Why?
|
| Self Tolerance | 1 | 2006 | 25 | 0.270 |
Why?
|
| Arthritis, Experimental | 1 | 2006 | 26 | 0.270 |
Why?
|
| Immunoglobulin A | 2 | 2003 | 83 | 0.270 |
Why?
|
| Peyer's Patches | 2 | 2003 | 18 | 0.240 |
Why?
|
| Lymphotoxin beta Receptor | 9 | 2007 | 29 | 0.230 |
Why?
|
| Intestines | 2 | 2003 | 416 | 0.220 |
Why?
|
| Signal Transduction | 5 | 2006 | 3403 | 0.190 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2016 | 366 | 0.180 |
Why?
|
| Epithelial Cells | 2 | 2006 | 689 | 0.160 |
Why?
|
| Cell Transformation, Viral | 1 | 1998 | 38 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1998 | 79 | 0.150 |
Why?
|
| Chromosome Deletion | 1 | 1998 | 227 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2003 | 591 | 0.140 |
Why?
|
| Mice | 16 | 2009 | 11851 | 0.130 |
Why?
|
| Lymphoid Tissue | 2 | 2006 | 57 | 0.120 |
Why?
|
| Spleen | 4 | 2003 | 433 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 485 | 0.120 |
Why?
|
| Membrane Proteins | 4 | 2006 | 1227 | 0.120 |
Why?
|
| Prostate | 1 | 1998 | 402 | 0.120 |
Why?
|
| Animals | 19 | 2016 | 27526 | 0.120 |
Why?
|
| Mice, Knockout | 8 | 2006 | 2015 | 0.110 |
Why?
|
| Immune Tolerance | 3 | 2006 | 341 | 0.110 |
Why?
|
| Lymphocyte Activation | 3 | 2006 | 754 | 0.110 |
Why?
|
| Cell Movement | 3 | 2006 | 786 | 0.100 |
Why?
|
| T-Lymphocytes | 5 | 2004 | 1221 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2006 | 700 | 0.100 |
Why?
|
| Psoriasis | 1 | 2014 | 245 | 0.090 |
Why?
|
| Mice, Nude | 2 | 2006 | 816 | 0.090 |
Why?
|
| Mice, Transgenic | 8 | 2007 | 1576 | 0.090 |
Why?
|
| Biomarkers, Tumor | 2 | 2016 | 1544 | 0.090 |
Why?
|
| Lymph Nodes | 3 | 2003 | 550 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2013 | 284 | 0.090 |
Why?
|
| Cell Differentiation | 2 | 2016 | 1533 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 6 | 2006 | 3252 | 0.080 |
Why?
|
| Receptors, Chemokine | 3 | 2003 | 31 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 598 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2014 | 952 | 0.080 |
Why?
|
| Chemotaxis | 1 | 2007 | 73 | 0.070 |
Why?
|
| CD4 Antigens | 2 | 2007 | 83 | 0.070 |
Why?
|
| Neoplasms, Experimental | 1 | 2009 | 269 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2009 | 600 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 1098 | 0.070 |
Why?
|
| NF-kappa B p52 Subunit | 1 | 2006 | 5 | 0.070 |
Why?
|
| Chemokines, CC | 2 | 2003 | 36 | 0.070 |
Why?
|
| Lymphotoxin-beta | 1 | 2006 | 7 | 0.070 |
Why?
|
| Polyendocrinopathies, Autoimmune | 1 | 2006 | 3 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2006 | 2887 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 1054 | 0.060 |
Why?
|
| Islets of Langerhans | 2 | 2006 | 549 | 0.060 |
Why?
|
| Dendritic Cells, Follicular | 2 | 2002 | 20 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2013 | 1061 | 0.060 |
Why?
|
| Killer Cells, Natural | 2 | 2004 | 276 | 0.060 |
Why?
|
| Autoantigens | 1 | 2006 | 129 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2007 | 312 | 0.060 |
Why?
|
| Antigens, Ly | 1 | 2004 | 37 | 0.060 |
Why?
|
| Lymphocyte Subsets | 1 | 2004 | 66 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2006 | 276 | 0.060 |
Why?
|
| Combined Modality Therapy | 3 | 2014 | 1704 | 0.060 |
Why?
|
| Lymphoma, T-Cell | 1 | 2004 | 55 | 0.060 |
Why?
|
| Sarcoma, Experimental | 1 | 2004 | 53 | 0.060 |
Why?
|
| B7-1 Antigen | 1 | 2004 | 76 | 0.060 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2003 | 19 | 0.060 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2003 | 77 | 0.060 |
Why?
|
| Flow Cytometry | 3 | 2016 | 690 | 0.060 |
Why?
|
| Blood Proteins | 1 | 2004 | 149 | 0.050 |
Why?
|
| Immunoglobulin E | 1 | 2003 | 145 | 0.050 |
Why?
|
| Receptors, CXCR4 | 1 | 2003 | 45 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 2331 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2003 | 166 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2006 | 434 | 0.050 |
Why?
|
| Immunity, Cellular | 1 | 2003 | 178 | 0.050 |
Why?
|
| Insulin | 2 | 2007 | 1148 | 0.050 |
Why?
|
| Chemokines, CXC | 1 | 2002 | 22 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2003 | 270 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2003 | 468 | 0.050 |
Why?
|
| Graft Rejection | 2 | 2004 | 1076 | 0.050 |
Why?
|
| Chemokine CCL21 | 3 | 2007 | 16 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 665 | 0.050 |
Why?
|
| B-Lymphocytes | 2 | 2002 | 740 | 0.040 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 14 | 3 | 2006 | 14 | 0.040 |
Why?
|
| Chemokines | 3 | 2007 | 74 | 0.040 |
Why?
|
| Peptides | 1 | 2004 | 649 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 1283 | 0.040 |
Why?
|
| Adenovirus E1A Proteins | 1 | 1998 | 7 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 1244 | 0.040 |
Why?
|
| Karyotyping | 1 | 1998 | 253 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 1998 | 154 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2004 | 885 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2004 | 693 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 1998 | 194 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 2362 | 0.040 |
Why?
|
| Humans | 10 | 2016 | 89924 | 0.040 |
Why?
|
| cdc25 Phosphatases | 1 | 2016 | 19 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2016 | 259 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2012 | 677 | 0.030 |
Why?
|
| Autoimmunity | 2 | 2006 | 169 | 0.030 |
Why?
|
| Immunoglobulins | 2 | 2006 | 143 | 0.030 |
Why?
|
| Cetuximab | 1 | 2014 | 115 | 0.030 |
Why?
|
| Leg | 1 | 2014 | 140 | 0.030 |
Why?
|
| Stromal Cells | 2 | 2006 | 151 | 0.030 |
Why?
|
| Adoptive Transfer | 2 | 2004 | 169 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 2004 | 524 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 2 | 2004 | 167 | 0.030 |
Why?
|
| Gene Expression Regulation | 3 | 2006 | 1983 | 0.020 |
Why?
|
| Keratins | 1 | 2012 | 63 | 0.020 |
Why?
|
| Urothelium | 1 | 2012 | 62 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2004 | 563 | 0.020 |
Why?
|
| Female | 6 | 2016 | 46571 | 0.020 |
Why?
|
| Gene Expression | 2 | 2004 | 1309 | 0.020 |
Why?
|
| Rats | 2 | 2007 | 4048 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 3796 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2012 | 1497 | 0.020 |
Why?
|
| Middle Aged | 2 | 2016 | 26132 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 4325 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2009 | 310 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2009 | 215 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2007 | 109 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 1134 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2009 | 476 | 0.020 |
Why?
|
| Male | 3 | 2016 | 42657 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2009 | 332 | 0.020 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2006 | 5 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2006 | 37 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2007 | 171 | 0.020 |
Why?
|
| Prediabetic State | 1 | 2006 | 36 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2006 | 198 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 2767 | 0.020 |
Why?
|
| Receptors, NK Cell Lectin-Like | 1 | 2004 | 5 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2004 | 58 | 0.010 |
Why?
|
| Ethylnitrosourea | 1 | 2004 | 30 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2004 | 44 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 961 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 2004 | 86 | 0.010 |
Why?
|
| Succinimides | 1 | 2004 | 12 | 0.010 |
Why?
|
| Oncogenes | 1 | 2004 | 97 | 0.010 |
Why?
|
| Fluoresceins | 1 | 2004 | 43 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 14 | 1 | 2004 | 7 | 0.010 |
Why?
|
| Interleukin-15 | 1 | 2004 | 73 | 0.010 |
Why?
|
| Stem Cells | 1 | 2006 | 376 | 0.010 |
Why?
|
| Receptors, CCR7 | 1 | 2003 | 16 | 0.010 |
Why?
|
| CD3 Complex | 1 | 2004 | 134 | 0.010 |
Why?
|
| Receptors, Virus | 1 | 2004 | 75 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2004 | 81 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2003 | 127 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2006 | 450 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 160 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2003 | 115 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 391 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 2003 | 75 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2004 | 371 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 6780 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 397 | 0.010 |
Why?
|
| Respiratory Mechanics | 1 | 2003 | 102 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 374 | 0.010 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2004 | 135 | 0.010 |
Why?
|
| Leukocytes | 1 | 2003 | 209 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 245 | 0.010 |
Why?
|
| Mucoproteins | 1 | 2002 | 14 | 0.010 |
Why?
|
| Receptors, CXCR5 | 1 | 2002 | 6 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 2002 | 28 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 692 | 0.010 |
Why?
|
| Chemokine CXCL13 | 1 | 2002 | 15 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 434 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2002 | 98 | 0.010 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2002 | 19 | 0.010 |
Why?
|
| Endocytosis | 1 | 2003 | 180 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2002 | 38 | 0.010 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2002 | 40 | 0.010 |
Why?
|
| Germinal Center | 1 | 2002 | 55 | 0.010 |
Why?
|
| Transgenes | 1 | 2002 | 185 | 0.010 |
Why?
|
| B7-H1 Antigen | 1 | 2004 | 278 | 0.010 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2004 | 242 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 431 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2004 | 250 | 0.010 |
Why?
|
| Vaccination | 1 | 2004 | 279 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 1048 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 909 | 0.010 |
Why?
|
| Cysteine | 1 | 2002 | 137 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 8270 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 5554 | 0.010 |
Why?
|
| Ligands | 1 | 2002 | 447 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2002 | 295 | 0.010 |
Why?
|
| Antibodies | 1 | 2002 | 353 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 1801 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2004 | 837 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 811 | 0.010 |
Why?
|
| Phenotype | 1 | 2006 | 2457 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 1158 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 19240 | 0.010 |
Why?
|
| Cell Line | 1 | 2003 | 2495 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2004 | 565 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2004 | 2026 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2002 | 559 | 0.010 |
Why?
|
| Lung | 1 | 2003 | 1292 | 0.010 |
Why?
|
| Apoptosis | 1 | 2003 | 1718 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 5357 | 0.010 |
Why?
|
| Pregnancy | 1 | 2002 | 3040 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 1591 | 0.010 |
Why?
|